KPMG LLP (financial and tax), Barclays Bank PLC (strategic advisory) and Skadden, Arps, Slate, Meagher & Flom LLP (legal) provided advisory services to Corin in support of the transaction. Piper Jaffray & Co. acted as financial advisor to OMNI and Foley Hoag LLP acted as legal advisor to OMNI.
UK International orthopaedic company Corin Group (“Corin”), backed by the Permira funds, has signed a binding agreement for the acquisition of US-based OMNI Orthopaedics Inc. (“OMNI”), a pioneer in robotic-assisted total knee replacement.
It is further evidence of Permira and their co-investors’ determination to accelerate Corin’s strong organic growth with a focussed M&A strategy.
Founded in 1999 by a team of medical device engineers, OMNI is now at the forefront of robotic-assisted knee replacement. Their OMNIBotics® is a unique imageless total knee replacement solution which combines a robotic cutting guide with the world’s first robotic tool to measure ligament function. The system allows tailoring of the implant positioning to each individual patient, resulting in less patient pain and faster rehabilitationi.
Corin’s strategy is to revolutionise orthopaedics by gaining, understanding and sharing insight at every stage of the joint replacement experience and delivering clinically proven implants which are optimised by unique procedural technologies. OMNIBotics®, combined with APEX knee replacement, accelerates Corin’s strategy.
Foley Hoag attorneys Eric Belsley (Picture), Erica Rice, Erica Harrington, Terry Martland, Kip Cawley, Chris Natkanski and Matthew Baltay represented OMNI in the transaction.
Involved fees earner: Matthew Baltay – Foley Hoag; Eric Belsley – Foley Hoag; Christopher Cawley – Foley Hoag; Erica Harrington – Foley Hoag; Teresa Martland – Foley Hoag; Christopher Natkanski – Foley Hoag; Erica Rice – Foley Hoag;
Law Firms: Foley Hoag;
Clients: OMNI Orthopaedics, Inc.;